-
1Academic Journal
Source: Клиническая онкогематология, Vol 6, Iss 1 (2025)
-
2Academic Journal
Source: ВЕСТНИК ОБРАЗОВАНИЯ И РАЗВИТИЯ НАУКИ РОССИЙСКОЙ АКАДЕМИИ ЕСТЕСТВЕННЫХ НАУК. :72-76
Subject Terms: герпесвирусные инфекции, инфекция COVID-19, онкогематологические заболевания, 3. Good health
-
3Academic Journal
Authors: Strokan, A.M., Subbotin, V.Yu.
Source: МЕДИЦИНА НЕВІДКЛАДНИХ СТАНІВ; Том 16, № 2 (2020); 111-114
МЕДИЦИНА НЕОТЛОЖНЫХ СОСТОЯНИЙ; Том 16, № 2 (2020); 111-114
EMERGENCY MEDICINE; Том 16, № 2 (2020); 111-114Subject Terms: центральный венозный катетер, периферически установленный центральный катетер, онкогематологические заболевания, 03 medical and health sciences, центральний венозний катетер, периферично встановлений центральний катетер, онкогематологічні захворювання, central venous catheter, peripherally inserted central catheter, oncohematological diseases, 0302 clinical medicine, 3. Good health
File Description: application/pdf
-
4Academic Journal
Source: Клиническая онкогематология, Vol 14, Iss 2 (2021)
-
5Report
Subject Terms: neutropenic fever, иммуносупрессия, oncohematological diseases, infection prevention, антимикробная резистентность, opportunistic infections, chemotherapy, оппортунистические инфекции, infectious complications, химиотерапия, immunosuppression, инфекционные осложнения, профилактика инфекций, antimicrobial resistance, нейтропеническая лихорадка, онкогематологические заболевания
-
6Academic Journal
Authors: Golban, R., Lisiţa, N.I., Dediu, L.
Source: Buletinul Academiei de Ştiinţe a Moldovei. Ştiinţe Medicale 76 (2) 74-78
Subject Terms: SARS-CoV-2 infection, onco-hematological diseases, hemoblastosis, инфекция SARS-COV-2, онкогематологические заболевания, гемобластозы
File Description: application/pdf
Relation: https://ibn.idsi.md/vizualizare_articol/193397; urn:issn:18570011
-
7Academic Journal
Authors: T. V. Glazanova, E. R. Shilova, Т. В. Глазанова, Е. Р. Шилова
Source: Journal Infectology; Том 14, № 4 (2022); 26-37 ; Журнал инфектологии; Том 14, № 4 (2022); 26-37 ; 2072-6732 ; 10.22625/2072-6732-2022-14-4
Subject Terms: онкогематологические заболевания, cell immunity, post-COVID syndrome, hematologic malignancies, клеточный иммунитет, постковидный синдром
File Description: application/pdf
Relation: https://journal.niidi.ru/jofin/article/view/1377/989; Болевич, C.Б. Комплексный механизм развития СOVID-19 / С.Б. Болевич, С.С. Болевич // Сеченовский вестник. – 2020. – № 11 (2). – С. 50–61. – doi:10.47093/2218-7332.2020.11.2.50-61.; Sette A., Crotty S. Adaptive immunity to SARS-CoV-2 and COVID-19. Cell. 2021;184(4):861-880. doi:10.1016/j.cell.2021.01.007; Mohn K.G., Br edholt G., Zhou F. et al. Durable T-cellular and humoral responses in SARS-CoV-2 hospitalized and community patients. PloS ONE, 2022;17(2):e0261979. doi:10.1371/journal.pone.0261979; Malkova A.; Kudryavtsev I., Starshinova A. et al. Post COVID-19 Syndrome in Patients with Asymptomatic/Mild Form. Pathogens. 2021;10:1408. doi:10.3390/pathogens10111408; Wu J., Tang L., Ma Y. et al. Immunological Profiling of COVID-19 Patients with Pulmonary Sequelae. mBio. 2021;12(5):e0159921. doi:10.1128/mBio.01599-21; Nalbandian A., Sehgal K., Gupta A. et al. Post-acute COVID-19 syndrome. Nat. Med. 2021; 27: 601–615. doi:10.1038/s41591-021-01283-z; Liu C., Martins A.J., Lau W.W.et al. Time-resolved systems immunology reveals a late juncture linked to fatal COVID-19. Cell Volume. 2021; 184(7):1836-1857.e22 doi:10.1016/j.cell.2021.02.018; Wong R.S., Wu A., To K.F. et al. Haematological manifestations in patients with severe acute respiratory syndrome: retrospective analysis. BMJ 2003;326(7403):1358–1362. doi:10.1136/bmj.326.7403.1358; Li T., Qiu Z, Zhang L. et al. Significant changes of peripheral T lymphocyte subsets in patients with severe acute respiratory syndrome. J Infect Dis. 2004;189(4):648–51. doi:10.1086/381535; Zheng H.Y., Zhang M., Yang C.X,. et al. Elevated exhaustion levels and reduced functional diversity of T cells in peripheral blood may predict severe progression in COVID-19 patients. Cell Mol Immunol. 2020;17(5):541-543. doi:10.1038/s41423-020-0401-3; Diao B., Wang C., Tan Y. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front Immunol 2020;11:827 doi:10.3389/fimmu.2020.00827; Chen J., Lau Y.F., Lamirande E.W. et al. Cellular immune responses to severe acute respiratory syndrome coronavirus (SARSCoV) infection in senescent BALB/c mice: CD4+T cells are important in control of SARS-CoV infection. J Virol. 2010;84(3):1289–1301. doi:10.1128/JVI.01281-09.; Zheng M., Gao Y., Wang G. et al. Functional exhaustion of antiviral lymphocytes in COVID-19 patients. Cellular & Molecular Immunology. 2020;17:533–535. doi:10.1038/s41423-020-0402-2; Braun J., Loyal L., Frentsch M. et al. SARS-CoV-2-reactive T cells in healthy donors and patients with COVID-19. Nature. 2020;587(7833):270-274. doi:10.1038/s41586-020-2598-9; Rydyznski Moderbacher C., Ramirez S.I., Dan J.M., et al. Antigen-Specific Adaptive Immunity to SARS-CoV-2 in Acute COVID-19 and Associations with Age and Disease Severity. Cell. 2020;183(4):996-1012.e19. doi:10.1016/j.cell.2020.09.038; Schulien I, Kemming J, Oberhardt V, et al. Characterization of pre-existing and induced SARS-CoV-2-specific CD8 + T cells. Nat Med. 2021;27(1):78-85. doi:10.1038/s41591-020-01143-2; Liu Y., Zhang C., Huang F. et al. Elevated plasma levels of selective cytokines in COVID-19 patients reflect viral load and lung injury. Sci. Rev. 2020;7:1003–1011. doi:10.1093/nsr/nwaa037; Shin H.-S., Kim Y., Kim G. et al. Immune responses to middle east respiratory syndrome coronavirus during the acute and convalescent phases of human infection. Clin Infect Dis. 2019; 68: 984–992. doi:10.1093/cid/ciy595; Bernardes J.P., Mishra N., Tran F. et al. Longitudinal Multiomics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19. Immunity. 2020;53(6):1296-1314.e9. doi:10.1016/j.immuni.2020.11.017.; Mathew D., Giles J.R., Baxter A.E. et al. Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications. Science. 2020;369(6508):eabc8511. doi:10.1126/SCIENCE.ABC8511; Zhou F., Yu T., Du R. et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. doi:10.1016/S0140-6736(20)30566-3.; Vuitton D.A., Vuitton L., Seillès E., Galanaud P. A plea for the pathogenic role of immune complexes in severe Covid-19. Clin Immunol. 2020;217:108493. doi:10.1016/j.clim.2020.108493.; Delanghe J.R., De Buyzere M.L, Speeckaert M.M. C3 and ACE1 polymorphisms are more important confounders in the spread and outcome of COVID-19 in comparison with ABO polymorphism. Eur J Prev Cardiol. 2020;27(12):1331–1332. doi:10.1177/2047487320931305.; Fang S., Wang H., Lu L.et al. Decreased complement C3 levels are associated with poor prognosis in patients with COVID-19: a retrospective cohort study. Int Immunopharmacol 2020; 89(Pt A):107070. doi:10.1016/j.intimp.2020.107070; Rapkiewicz A.V., Mai X., Carsons S.E. et al. Megakaryocytes and plateletfibrin thrombi characterize multi-organ thrombosis at autopsy in COVID 19: a case series. E Clinical Medicine 2020;24:100434. doi:10.1016/j.eclinm.2020.100434.; Battina H., Alentado V., Srour E. et al. Interaction of the inflammatory response and megakaryocytes in COVID-19 infection. Exp Hematol 2021; 104: .32-39. doi:10.1016/j.exphem.2021.09.005; Ragab D., Salah Eldin H., Taeimah M. et al. The COVID-19 cytokine storm: What we know so far. Front Immunol. 2020;11:1446. doi:10.3389/fimmu.2020.01446; Behrens K., Alexander W.S. Cytokine control of megakaryopoiesis. Growth Factors. 2018;36:89–103. doi:10.1080/08977194.2018.1498487; Baig A.M. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021;93(5):2555-2556. doi:10.1002/jmv.26624; Sudre C.H., Murray B., Varsavsky T. et al. Attributes and predictors of long COVID. Nature medicine. 2021; 27(4): 626–631. doi:10.1038/s41591-021-01292-y; Chertow D., Stein S., Ramelli S. et al. SARS-CoV-2 infection and persistence throughout the human body and brain, 20 December 2021, PREPRINT (Version 1) available at Research Square https://doi.org/10.21203/rs.3.rs-1139035/v1; Su Y., Yuan D., Chen D.G. et al. Multiple Early Factors Anticipate Post-Acute COVID-19. Cell. 2022;185(5):881-895.e20. doi:10.1016/j.cell.2022.01.014; 33 Orologas-Stavrou N., Politou M., Rousakis P. et al. Peripheral blood immune profiling of convalescent plasma donors reveals alterations in specific immune subpopulations even at 2 months post sars-cov-2 infection. Viruses. 2021; 13: 26. doi.org/10.3390/v13010026; Knochelmann H.M., Dwyer C.J., Bailey, S.R. et al. When worlds collide: Th17 and Treg cells in cancer and autoimmunity. Cell. Mol. Immunol. 2018;15(5):458-469. doi:10.1038/s41423-018-0004-4; Gong F., Dai Y., Zheng T. et al. Peripheral CD4+ T cell subsets and antibody response in COVID-19 convalescent individuals. J. Clin. Investig. 2020; 130: 6588–6599. doi:10.1172/JCI141054; Kurata I., Matsumoto I., Sumida T. T follicular helper cell subsets: A potential key player in autoimmunity. Immunol. Med. 2021; 44: 1–9. doi:10.1080/25785826.2020.1776079; Shuwa H.A., Shaw T.N., Knight S.B. et al. Alterations in T and B cell function persist in convalescent COVID-19 patients. Med. 2021;2(6): 720–735.e4 doi.org/10.1016/j.medj.2021.03.013; Chen Q., Yu B,. Yang Y., et al. Immunological and inflammatory profiles during acute and convalescent phases of severe/critically ill COVID-19 patients. Int Immunopharmacol. 2021;97:107685. doi:10.1016/j.intimp.2021.107685; Le Bert N., Clapham H., Tan A. et al. Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection. J. Exp. Med. 2021;218(5).e20202617 doi:10.1084/jem.20202617; Zhao B., Zhong M., Yang Q. et al. Alterations in Phenotypes and Responses of T Cells Within 6 Months of Recovery from COVID-19: A Cohort Study. Virol Sin. 2021;36(5):859-868. doi:10.1007/s12250-021-00348-0; Sekine T., Perez-Potti A, Rivera-Ballesteros O. et al. Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19 Cell. 2020;183(1):158-168.e14. doi:10.1016/j.cell.2020.08.017; Rodríguez Y., Novelli L., Rojas M. et al. Autoinflammatory and autoimmune conditions at the crossroad of COVID-19. J Autoimmun. 2020;114:102506. doi:10.1016/j.jaut.2020.102506; Ehrenfeld M., Tincani A., Andreoli L., et al. Covid-19 and autoimmunity. Autoimmun Rev. 2020;19(8):102597. doi:10.1016/j.autrev.2020.102597; Druyan A., Lidar M., Brodavka M. et al. The risk for severe COVID 19 in patients with autoimmune and/or inflammatory diseases: first wave lessons. Dermatol Ther. 2021;34(1):e14627. doi:10.1111/dth.14627; Поддубная, И.В. Особенности ведения онкогематологических пациентов в условиях пандемии COVID-19 / И.В. Поддубная [и др.] // Современная Онкология. – 2020. – № 22 (3). – С. 45–58. – doi:10.26442/18151434.2020.3.200152; The Lancet Oncology. COVID-19 and cancer: 1 year on. Lancet Oncol. 2021; 22(4):411. doi:10.1016/S1470-2045(21)00148; Dulеry R., Lamure S., Delord M. et al. Prolonged in-hospital stay and higher mortality after Covid-19 among patients with nonHodgkin lymphoma treated with B-cell depleting immunotherapy. Am J Hematol. 2021;96:934–44. doi:10.1002/ajh.26209; Goronzy J.J., Weyand C.M. Successful and maladaptive T cell aging. Immunity. 2017;46(3):364–78. doi:10.1016/j.immuni.2017.03.010; Scully E.P., Haverfield J., Ursin R.L. et al. Considering how biological sex impacts immune responses and COVID-19 outcomes. Nat Rev Immunol. 2020;20:442–447. doi:10.1038/s41577-020-0348-8; Peckham, H., de Gruijter N., Raine C. et al. Sex-bias in COVID-19: a meta-analysis and review of sex differences in disease and immunity, 20 April 2020, PREPRINT (Version 2) available at Research Square. doi:10.21203/rs.3.rs-23651/v2; Abdullah M., Chai P-S., Chong M-Y. et al. Gender effect on in vitro lymphocyte subset levels of healthy individuals. Cell Immunol. 2012;272(2):214–219. doi:10.1016/j.cellimm.2011.10.009; Grifoni A., Weiskopf D., Ramirez S.I. et al. Targets of T Cell Responses to SARS-CoV-2 Coronavirus in Humans with COVID-19 Disease and Unexposed Individuals. Cell. 2020;181(7):1489-1501. e15. doi:10.1016/j.cell.2020.05.015; Mato A., Roeker L., Lamanna N. et al. Outcomes of COVID-19 in patients with CLL: a multicenter international experience. Blood. 2020;136(10):1134–1143. doi:10.1182/blood.2020006965; Lee C., Shah M., Hoyos D. et al. Prolonged SARS-CoV-2 Infection in Patients with Lymphoid Malignancies. Cancer Discov. 2022;12(1):62–73. doi:10.1158/2159-8290.CD-21-1033; Tamariz-Amador L.E., Battaglia A., Maia C. et al. Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies. Blood Cancer J. 2021;11(12):202. doi:10.1038/s41408-021-00594-1; Chung D., Shah G., Devlin S. et al. Disease- and TherapySpecific Impact on Humoral Immune Responses to COVID-19 Vaccination in Hematologic Malignancies. Blood Cancer Discov. 2021;2 (6): 568–576. doi:10.1158/2643-3230.BCD-21-0139; Maneikis K., Šablauskas K., Ringelevičiūtė U., et al. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study. Lancet Haematol. 2021;8(8):e583-e592.; Addeo A., Shah P.K., Bordry N. et al. Immunogenicity of SARSCoV-2 messenger RNA vaccines in patients with cancer. Cancer Cell. 2021;39(8):1091–1098.e2. doi:10.1016/j.ccell.2021.06.009; Tvito A., Ronson A., Ghosheh R. et al. Anti-CD20 monoclonal antibodies inhibit seropositive response to Covid-19 vaccination in non-Hodgkin lymphoma patients within 6 months after treatment. Exp. Hematol. 2022;107:20-23. doi:10.1016/j.exphem.2021.12.396.; Jotschke S., Schulze S., Jaekel N. et al. Longitudinal Humoral and Cellular Immune Responses Following SARS-CoV-2 Vaccination in Patients with Myeloid and Lymphoid Neoplasms Compared to a Reference Cohort: Results of a Prospective Trial of the East German Study Group for Hematology and Oncology (OSHO). Cancers (Basel). 2022;14(6):1544. doi:10.3390/cancers14061544; https://journal.niidi.ru/jofin/article/view/1377
-
8Academic Journal
Authors: Polina G. Gabay, Sophia A. Dronova, П. Г. Габай, С. А. Дронова
Contributors: Not specified, Не указан
Source: Current Pediatrics; Том 20, № 4 (2021); 327-332 ; Вопросы современной педиатрии; Том 20, № 4 (2021); 327-332 ; 1682-5535 ; 1682-5527
Subject Terms: порядок оказания медицинской помощи, pediatric oncology/hematology, oncological diseases, hematological diseases, oncohematological diseases, procedure for providing medical care, детская онкология-гематология, онкологические заболевания, гематологические заболевания, онкогематологические заболевания
File Description: application/pdf
-
9Academic Journal
Authors: T. V. Antonova, O. E. Pobegalova, M. S. Nozhkin, M. A. Romanova, O. V. Gorchakova, Т. В. Антонова, О. Е. Побегалова, М. С. Ножкин, М. А. Романова, О. В. Горчакова
Source: Journal Infectology; Том 12, № 5 (2020); 85-92 ; Журнал инфектологии; Том 12, № 5 (2020); 85-92 ; 2072-6732 ; 10.22625/2072-6732-2020-12-5
Subject Terms: одногодичная выживаемость, chronic hepatitis C infection, hematologic malignancies, hemopoietic stem cell transplantation, one-year survival, хронический гепатит С, онкогематологические заболевания, трансплантация гемопоэтических стволовых клеток
File Description: application/pdf
Relation: https://journal.niidi.ru/jofin/article/view/1148/853; Злокачественные новообразования в России в 2018 году (заболеваемость и смертность) / под ред. А.Д. Капри на [и др.] – М.: МНИОМ им. А.П.Герцена – филиал ФГБУ «НМИЦ радиологии» Минздрава России, 2019. – 250 с.; Жигулева, Л.Ю. Анализ показателей выживаемости больных гемобластозами в Санкт-Петербурге на популяционном уровне / Л.Ю. Жигулева, К.М. Абдулкадыров // Вестник Санкт-Петербургского университета. Медицина. – 2016. – Т.11, № 3. – С. 111–121; Ruhnke M, Arnold R, Gastmeier P. Infection control issues in patients with haematological malignancies in the era of multidrug-resistant bacteria. The Lancet. 2014 Dec;15(13):E606-19.; Bollard CM, Heslop HE. T cells for viral infections after allogeneic hematopoietic stem cell transplant. Blood. 2016 Jun 30;127(26):3331-40.; ВОЗ: Глобальный доклад по гепатиту, 2017 г. WHO/ HIV/2017.06 https://www.who.int/hepatitis/publications/global-hepatitis-report2017; Stern L, Withers B, Avdic S, et al. Human Cytomegalovirus Latency and Reactivation in Allogeneic Hematopoietic Stem Cell Transplant Recipients. Front Microbiol. 2019 May;10:1186. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546901/pdf/fmicb-10-01186.pdf (дата обращения 20.10.2020); Styczynski J. Who Is the Patient at Risk of CMV Recurrence: A Review of the Current Scientific Evidence with a Focus on Hematopoietic Cell Transplantation. Infect Dis Ther. 2018 Mar;7(1):1-16.; Giménez E, Torres I, Albert E, et al. Cytomegalovirus (CMV) infection and risk of mortality in allogeneic hematopoietic stem cell transplantation (Allo-HSCT): A systematic review, meta-analysis, and meta-regression analysis. Am J Transplant. 2019 Sep;19(9):2479-94.; Blyth E, Withers B, Clancy L, Gottlieb D. CMV-specific immune reconstitution following allogeneic stem cell transplantation. Virulence. 2016 Nov 16;7(8):967-80.; Васильева, В.А. Геморрагический цистит как осложнение после трансплантации аллогенных гемопоэтических стволовых клеток / В.А. Васильева [и др.] // Cellular Therapy and Transplantation. – 2017. – Т. 6, № 3. – С. 89–91.; Дмитрова, А.А. Влияние режимов профилактики реакции «трансплантат против хозяина» на восстановление ЦМВ-специфичного Т-клеточного иммунитета у пациентов после трансплантации аллогенных гемопоэтических стволовых клеток / А.А. Дмитрова [и др.] // Материалы докладов V Конгресса гематологов России. Гематология и трансфузиология. – 2020. – Т. 65, № 1. – Приложение № 1 – С.139.; Рудакова, Т.А. Тяжелая гипофункция трансплантата после аллогенной трансплантации гемопоэтических стволовых клеток у взрослых пациентов: частота, факторы риска, исходы / Т.А. Рудакова [и др.] // Клиническая онкогематология. Фундаментальные исследования и клиническая практика. – 2019. – Т.12, №3. – С. 309–318.; Ward KN, Hill JA, Hubacek P, et al; 2017 European Conference on Infections in Leukaemia (ECIL). Guidelines from the 2017 European Conference on Infections in Leukaemia for management of HHV-6 infection in patients with hematologic malignancies and after hematopoietic stem cell transplantation. Haematologica. 2019 Nov;104(11):2155-63.; Morris MI, Kotton CN, Wolfe C (Eds.). Emerging Transplant Infections: Clinical Challenges and Implications. 1st ed. Springer Nature Switzerland AG 2020. Haidar G. HHV-6, HHV-7, and HHV-8: Forgotten Viruses in Transplantation. https://link.springer.com/referenceworkentry/10.1007/978-3-030-01751-4_28-1 (дата обращения: 20.10.2020); Alves B, Torregrossa VR, Braz-Silva PH, et al. The Presence of CMV and HSV-1 Reactivation in Saliva May Play a Role in the Oral Mucositis Severity. Biology of Blood and Marrow Transplantation 2017 March 23(3):S266.; Ramos CA, Saliba RM, de Pádua L, et al. Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies. Haematologica. 2009 Feb;94(2):249-57.; Peffault de Latour R, Ribaud P, Robin M, et al. Allogeneic hematopoietic cell transplant in HCV-infected patients. J Hepatol. 2008 Jun;48(6):1008-17.; Arcaini L, Vallisa D, Rattotti S, et al. Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi. Ann Oncol. 2014 Jul;25(7):1404-10.; Kyvernitakis A, Mahale P, Popat UR, Jiang Y. Hepatitis C virus infection in patients undergoing hematopoietic cell transplantation in the era of direct-acting antiviral agents. Biol Blood Marrow Transplant. 2016 Apr; 22(4): 717-22.; Cunningham HE, Shea TC, Grgic T, Lachiewicz AM. Successful treatment of hepatitis C virus infection with directacting antivirals during hematopoietic cell transplant. Transpl Infect Dis 2019 Jun 26;21(3):e13091.; https://journal.niidi.ru/jofin/article/view/1148
-
10Academic Journal
Authors: Shapovalova, А. А.
Source: Bulletin of Scientific Research; No. 4 (2017) ; Вестник научных исследований; № 4 (2017) ; Вісник наукових досліджень; № 4 (2017) ; 2415-8798 ; 1681-276X ; 10.11603/2415-8798.2017.4
Subject Terms: children, oncohematological diseases, psychosomatic state, rehabilitation, mineral water, дети, онкогематологические заболевания, психосоматическое состояние, реабилитация, минеральная вода, діти, онкогематологічні захворювання, психосоматичний стан, реабілітація, мінеральна вода
File Description: application/pdf
Relation: https://ojs.tdmu.edu.ua/index.php/visnyk-nauk-dos/article/view/8319/7820; https://repository.tdmu.edu.ua//handle/123456789/12627
-
11Academic Journal
Authors: L. V. Vdovina, N. V. Tiunova, S. M. Tolmacheva, I. N. Usmanova
Source: Эндодонтия Today, Vol 18, Iss 2, Pp 68-72 (2020)
Subject Terms: микоз, геотрихоз, кандидоз, вич-инфекция, онкогематологические заболевания, противогрибковые препараты, иммунодефицитные состояния, стоматит, грибковые заболевания, Dentistry, RK1-715
Relation: https://www.endodont.ru/jour/article/view/892; https://doaj.org/toc/1683-2981; https://doaj.org/toc/1726-7242; https://doaj.org/article/a7d8799411d444f7bd51854c09dc7d1b
-
12Academic Journal
Subject Terms: type of relationship to the disease, детско-родительские отношения, подростковый возраст, adolescence, hematologic diseases, parent-child relationships, онкогематологические заболевания, тип отношения к болезни, 3. Good health
Access URL: https://research-journal.org/wp-content/uploads/2020/05/5-3-95.pdf#page=211
https://research-journal.org/psycology/vzaimosvyaz-tipa-otnosheniya-k-bolezni-i-otnosheniya-k-roditelyam-u-podrostkov-stradayushhix-onkogematologicheskimi-zabolevaniyami/ -
13Academic Journal
Authors: Shishkina, E. S., Tarakanova, Y. L., Fokina, E. S., Шишкина, Е. С., Тараканова, Ю. Л., Фокина, Е. С.
Subject Terms: POLYNEUROPATHIES, GUILLAIN-BARRЕ SYNDROME, HEMATOLOGIC DISEASES, LEUCOSIS, ПОЛИНЕЙРОПАТИИ, СИНДРОМ ГИЙЕНА-БАРРЕ, ОНКОГЕМАТОЛОГИЧЕСКИЕ ЗАБОЛЕВАНИЯ, ЛЕЙКОЗЫ
File Description: application/pdf
Relation: Уральский медицинский журнал. 2019. № 13(181).; http://elib.usma.ru/handle/usma/18779
Availability: http://elib.usma.ru/handle/usma/18779
-
14Academic Journal
Subject Terms: хронічний мієлолейкоз, онкогематологічні захворювання, неврологічні порушення, нейротоксичність, хіміотерапія, онкогематологические заболевания, неврологические нарушения, нейротоксичность, химиотерапия, chronic myelogenous leukemia, oncohematological diseases, neurological disorders, neurotoxicity, chemotherapy, 616.83-071: [616.4-008.8+616.155.392]
File Description: application/pdf
Relation: Піддубна О. О. Клінічні особливості ураження нервової системи при хронічному мієлолейкозі / О. О. Піддубна // Вісник проблем біології та медицини. – 2019. – Вип. 2, т. 2 (151). – С. 147–150.; https://repository.pdmu.edu.ua/handle/123456789/12450
-
15Academic Journal
Subject Terms: медицина, онкология, остеомиелит челюсти, онкогематологические заболевания, пожилой возраст
Availability: http://dspace.bsu.edu.ru/handle/123456789/43128
-
16Academic Journal
Source: Клиническая онкогематология, Vol 8, Iss 2 (2015)
-
17Academic Journal
Subject Terms: 5. Gender equality, детско-родительские отношения, подростковый возраст, adolescence, hematologic diseases, parent-child relationships, онкогематологические заболевания, 3. Good health
Access URL: https://research-journal.org/wp-content/uploads/2019/12/12-2-90-1.pdf#page=79
https://research-journal.org/en/psychology/osobennosti-otnosheniya-k-roditelyam-u-podrostkov-stradayushhix-onkogematologicheskimi-zabolevaniyami/
https://cyberleninka.ru/article/n/osobennosti-otnosheniya-k-roditelyam-u-podrostkov-stradayuschih-onkogematologicheskimi-zabolevaniyami -
18
-
19Academic Journal
Authors: Shishkina, E. S., Baidina, T. V., Fokina, E. S., Minaeva, N. V., Шишкина, Е. С., Байдина, Т. В., Фокина, Е. С., Минаева, Н. В.
Subject Terms: ONCOHEMATOLOGICAL DISEASES, POLYNEUROPATHY, MULTIPLE MYELOMA, POST-CHEMOTHERAPY POLYNEUROPATHY, ОНКОГЕМАТОЛОГИЧЕСКИЕ ЗАБОЛЕВАНИЯ, ПОЛИНЕЙРОПАТИИ
File Description: application/pdf
Relation: Уральский медицинский журнал. 2018. Т. 166, № 11.; http://elib.usma.ru/handle/usma/12918
Availability: http://elib.usma.ru/handle/usma/12918
-
20Academic Journal
Authors: Boronina, L. G., Samatova, E. V., Kukushkina, M. P., Panova, S. A., Fechina, L. G., Боронина, Л. Г., Саматова, Е. В., Кукушкина, М. П., Панова, С. А., Фечина, Л. Г.
Source: Вестник Уральского государственного медицинского университета
Subject Terms: INFECTIOUS COMPLICATIONS, AETIOLOGY, ONCOHEMATOLOGICAL DISEASES, CHILDREN, ИНФЕКЦИОННЫЕ ОСЛОЖНЕНИЯ, ЭТИОЛОГИЯ, ОНКОГЕМАТОЛОГИЧЕСКИЕ ЗАБОЛЕВАНИЯ, ДЕТИ
File Description: application/pdf
Relation: Вестник Уральского государственного медицинского университета. 2018. №2; http://elib.usma.ru/handle/usma/469
Availability: http://elib.usma.ru/handle/usma/469